S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
OTCMKTS:CGRW

CannaGrow Stock Forecast, Price & News

$0.28
+0.08 (+36.59 %)
(As of 01/15/2021 08:27 PM ET)
Add
Compare
Today's Range
$0.19
Now: $0.28
$0.28
50-Day Range
$0.11
MA: $0.16
$0.29
52-Week Range
$0.03
Now: $0.28
$0.30
Volume783,000 shs
Average Volume435,940 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
CannaGrow Holdings, Inc. develops, designs, and builds grow facilities for legal cannabis industry in the State of Colorado. It offers design, permitting, development and construction, site management, staffing, research, and other professional services. The company was formerly known as BizAuctions, Inc. and changed its name to CannaGrow Holdings, Inc. in November 2014. CannaGrow Holdings, Inc. is based in Greenwood Village, Colorado.

MarketRank

Overall MarketRank

0.44 out of 5 stars

Industrials Sector

203rd out of 259 stocks

Business Services Industry

23rd out of 24 stocks

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Business Services
Sub-IndustryN/A
Current SymbolOTCMKTS:CGRW
CUSIPN/A
CIKN/A
Phone720-486-5309
Employees5

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
$0.28
+0.08 (+36.59 %)
(As of 01/15/2021 08:27 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CGRW News and Ratings via Email

Sign-up to receive the latest news and ratings for CGRW and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CannaGrow (OTCMKTS:CGRW) Frequently Asked Questions

How has CannaGrow's stock price been impacted by Coronavirus (COVID-19)?

CannaGrow's stock was trading at $0.11 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, CGRW shares have increased by 154.5% and is now trading at $0.28.
View which stocks have been most impacted by COVID-19
.

What stocks does MarketBeat like better than CannaGrow?

Wall Street analysts have given CannaGrow a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but CannaGrow wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of CannaGrow's key competitors?

What other stocks do shareholders of CannaGrow own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CannaGrow investors own include (CGC), Tilray (TLRY), Cannabis Science (CBIS), Cronos Group (CRON), KushCo (KSHB), MariMed (MRMD), Cross Timbers Royalty Trust (CRT), AbbVie (ABBV), Aurora Cannabis (ACB) and (APHA).

Who are CannaGrow's key executives?

CannaGrow's management team includes the following people:
  • Mr. Delmar A. Janovec, CEO & Pres
  • Mr. Brent Crouch, Chief Financial Officer
  • Mr. Rod Clawson, Exec. VP

What is CannaGrow's stock symbol?

CannaGrow trades on the OTCMKTS under the ticker symbol "CGRW."

How do I buy shares of CannaGrow?

Shares of CGRW can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CannaGrow's stock price today?

One share of CGRW stock can currently be purchased for approximately $0.28.

What is CannaGrow's official website?

The official website for CannaGrow is www.cannagrowholdings.com.

How can I contact CannaGrow?

The company can be reached via phone at 720-486-5309.

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.